IceCure Medical Ltd
ICCM
$0.30
$0.00-0.33%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 1.92% | 26.02% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 1.92% | 26.02% | |
| Cost of Revenue | -- | -- | -4.61% | 20.16% | |
| Gross Profit | -- | -- | 11.62% | 34.48% | |
| SG&A Expenses | -- | -- | 16.83% | 2.85% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 0.97% | -3.94% | |
| Operating Income | -- | -- | -0.77% | 9.36% | |
| Income Before Tax | -- | -- | -4.55% | 11.37% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | -- | -4.55% | 11.37% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -4.55% | 11.37% | |
| EBIT | -- | -- | -0.77% | 9.36% | |
| EBITDA | -- | -- | -0.73% | 9.67% | |
| EPS Basic | -- | -- | 6.51% | 20.74% | |
| Normalized Basic EPS | -- | -- | 5.30% | 32.52% | |
| EPS Diluted | -- | -- | 6.51% | 20.74% | |
| Normalized Diluted EPS | -- | -- | 5.30% | 32.52% | |
| Average Basic Shares Outstanding | -- | -- | 11.48% | 10.71% | |
| Average Diluted Shares Outstanding | -- | -- | 11.48% | 10.71% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |